KPMG is a proud sponsor of the DIA Global Annual Meeting. This forum brings industry, regulators, academics, and patients together to co-create, problem-solve, and discuss global and local challenges facing professionals in the life sciences community.
We encourage you to read our latest case studies and thought leadership
KPMG’s goal is to help our clients improve efficiency within their Regulatory Affairs function by implementing process and technology changes. These transformational changes help Life Sciences companies bring products to market more quickly, while reducing compliance risk and enabling a sustainable approach to regulatory activities.
As the world emerges into a "new normal" across life sciences due to the COVID-19 pandemic, we are entering a new phase of Precision Medicine (PM). Whether you are a medical institution developing personalized and holistic services for your patients in all therapeutic areas, the field of Precision Medicine has changed for everyone.
How life sciences companies can mitigate the challenges of the new EU Clinical Trials Regulation, accelerate their R&D, and become more competitive.
Businesses that incorporate AI as a part of a healthcare process will need to be alert to the current regulations in the medical device space, developing quality management processes to covert heir internal product development. Moreover, it is essential that these businesses are forward thinking when it comes to regulatory compliance.
KPMG capabilities and accelerators can enable more efficient client configuration of quality audit management functionality on TrackWise Digital platform by Sparta Systems.
